Standout Papers

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis 2017 2026 2020 2023 555
  1. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis (2017)
    Michael E. Wechsler, Praveen Akuthota et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Inflammatory response of nanoparticles: Mechanisms, consequences, and strategies for mitigation
2024 Standout
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
2024 Standout
3 intermediate papers

Works of Stephen Mallett being referenced

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
2017 Standout

Author Peers

Author Last Decade Papers Cites
Stephen Mallett 567 407 263 604 22 984
Abeed A. Pall 879 252 107 454 18 1.1k
Roger Silvestrini 546 208 167 347 20 1.1k
W L Gross 673 248 82 352 27 817
J. F. Niall 613 210 104 224 21 786
Caroline Roozendaal 296 118 98 335 35 880
Claudia Metzler 704 262 81 571 16 857
R. Cévallos 632 270 80 345 23 798
Elisabeth Peen 148 304 133 276 25 802
Peter Hewins 686 136 71 260 37 1.1k
Cinzia Tosoni 562 217 151 557 18 762

All Works

Loading papers...

Rankless by CCL
2026